How is semaglutide coded for diabetes management?

Semaglutide for diabetes is coded with E11.9 for Type 2 diabetes and Z79.899 for long-term use. Ensure semaglutide is specified in documentation.

What ICD-10 code is used for semaglutide in obesity?

For obesity, use E66.9 with a BMI code (e.g., Z68.30) and Z79.899 for long-term semaglutide use.

ICD-10 Coding for Semaglutide Therapy(E11.9, E10.9, E66.01)

Save

Comprehensive guide on semaglutide coding for diabetes and obesity, including ICD-10 codes, documentation requirements, and common pitfalls.

Also known as:

GLP-1 Agonist TherapyOzempicWegovy

Related ICD-10 Code Ranges

Complete code families applicable to Semaglutide Therapy

E00-E89Primary Range

Endocrine, nutritional and metabolic diseases

→

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

Code	Description	When to Use	Key Documentation
E11.9	Type 2 diabetes mellitus without complications	Use for patients diagnosed with Type 2 diabetes managed with semaglutide.	Diagnosis of Type 2 diabetes HbA1c levels
E66.9	Obesity, unspecified	Use for patients using semaglutide for weight management.	BMI ≥30 Failed lifestyle interventions
Z79.899	Other long-term (current) drug therapy	Use for documenting long-term semaglutide therapy.	Documentation of semaglutide use for ≥90 days
T46.5X5	Adverse effect of other antidiabetic drugs	Use for documenting adverse effects related to semaglutide.	Temporal relationship between semaglutide administration and adverse effect

Primary ICD-10-CM Codes

Type 2 diabetes mellitus without complications

E11.9Billable

Differential Codes

Alternative codes to consider when ruling out similar conditions

Type 1 diabetes mellitus without complicationsE10.9

Morbid (severe) obesity due to excess caloriesE66.01

Documentation & Coding Risks

Avoid these common issues when documenting Semaglutide Therapy.

Omitting drug name with J3490

Impact

Clinical: Incomplete medication records., Regulatory: Non-compliance with billing requirements., Financial: Potential claim denials.

Mitigation

Always specify the drug name in documentation.

Using Z79.4 (insulin) instead of Z79.899 for semaglutide

Impact

Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient medication records.

Mitigation

Ensure Z79.899 is used for non-insulin medications like semaglutide.

Not specifying semaglutide with J3490

Impact

Reimbursement: Claims may be denied without specific drug documentation., Compliance: Fails to meet documentation standards., Data Quality: Incomplete medication records.

Mitigation

Include 'semaglutide' in documentation when using J3490.

Incorrect Drug Coding

Impact

Failure to specify semaglutide can lead to audit issues.

Mitigation

Ensure all documentation includes specific drug names.

Frequently Asked Questions

Documentation requirements, coding pitfalls and FAQs for conditions coded with E11.9.

Primary Code

E11.9

Type 2 diabetes mellitus without complications

Quick Navigation

ICD-10 codes8

Coding risks4

FAQs2

ICD-10 Coding for Semaglutide Therapy(E11.9, E10.9, E66.01)

Documentation & Coding Risks

Frequently Asked Questions

How is semaglutide coded for diabetes management?

What ICD-10 code is used for semaglutide in obesity?

Related condition guides